View Filing Data

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2012	Jul. 31, 2012
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,625,708
Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		89,576,045
Class C
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		664,000
Class D
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		32,148

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net revenues before provision for doubtful accounts	$ 1,914,463	$ 1,869,414	$ 3,860,675	$ 3,744,842
Less: Provision for doubtful accounts	184,660	154,950	333,283	304,120
Net revenues	1,729,803	1,714,464	3,527,392	3,440,722
Operating charges:
Salaries, wages and benefits	856,878	836,559	1,730,872	1,667,317
Other operating expenses	347,412	349,454	700,985	688,811
Supplies expense	198,100	202,003	403,740	405,282
Depreciation and amortization	73,078	71,215	144,970	140,809
Lease and rental expense	24,003	22,996	47,465	45,853
Operating Expenses, Total	1,499,471	1,482,227	3,028,032	2,948,072
Income from operations	230,332	232,237	499,360	492,650
Interest expense, net	45,888	49,808	92,598	106,225
Income before income taxes	184,444	182,429	406,762	386,425
Provision for income taxes	67,000	66,395	146,748	140,404
Net income	117,444	116,034	260,014	246,021
Less: Income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Net income attributable to UHS	$ 107,561	$ 103,649	$ 236,168	$ 217,842
Basic earnings per share attributable to UHS	$ 1.11	$ 1.06	$ 2.44	$ 2.23
Diluted earnings per share attributable to UHS	$ 1.10	$ 1.04	$ 2.41	$ 2.20
Weighted average number of common shares-basic	96,691	97,563	96,642	97,472
Add: Other share equivalents	1,038	1,695	1,118	1,591
Weighted average number of common shares and equivalents-diluted	97,729	99,258	97,760	99,063

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net income	$ 117,444	$ 116,034	$ 260,014	$ 246,021
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	212	(20,583)	1,827	(18,276)
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income before tax	128	(20,667)	1,659	(18,444)
Income tax expense related to items of other comprehensive income	50	(7,916)	632	(7,056)
Total other comprehensive income, net of tax	78	(12,751)	1,027	(11,388)
Comprehensive income	117,522	103,283	261,041	234,633
Less: Comprehensive income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Comprehensive income attributable to UHS	$ 107,639	$ 90,898	$ 237,195	$ 206,454

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 32,941	$ 41,229	$ 34,816	$ 29,474
Accounts receivable, net	1,019,929	969,802
Supplies	96,882	96,775
Other current assets	99,534	99,859
Deferred income taxes	122,795	108,324
Current assets held for sale	84,365	48,916
Total current assets	1,456,446	1,364,905
Property and equipment	5,172,407	5,106,160
Less: accumulated depreciation	(1,875,492)	(1,818,180)
Property, Plant and Equipment, Net, Total	3,296,915	3,287,980
Other assets:
Goodwill	2,610,637	2,627,602
Deferred charges	106,095	111,780
Other	288,555	272,978
Total assets	7,758,648	7,665,245	$ 7,565,753
Current liabilities:
Current maturities of long-term debt	2,497	2,479
Accounts payable and accrued liabilities	852,256	832,125
Current liabilities held for sale	15,966	2,329
Federal and state taxes	12,893	0
Total current liabilities	883,612	836,933
Other noncurrent liabilities	393,928	401,908
Long-term debt	3,458,509	3,651,428
Deferred income taxes	206,403	209,592
Redeemable noncontrolling interests	226,537	218,266
UHS common stockholders' equity	2,536,884	2,296,352
Noncontrolling interest	52,775	50,766
Total equity	2,589,659	2,347,118
Liabilities and Equity, Total	$ 7,758,648	$ 7,665,245

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash Flows from Operating Activities:
Net income	$ 260,014	$ 246,021
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	148,703	144,949
Stock-based compensation expense	10,996	8,665
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(63,937)	(77,661)
Accrued interest	15,873	(2,309)
Accrued and deferred income taxes	3,955	55,420
Other working capital accounts	(13,085)	(48,417)
Other assets and deferred charges	13,866	11,525
Other	2,050	3,468
Accrued insurance expense, net of commercial premiums paid	42,241	47,480
Payments made in settlement of self-insurance claims	(47,814)	(33,365)
Net cash provided by operating activities	372,862	355,776
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(182,351)	(116,240)
Proceeds received from sale of assets and businesses	53,461	2,041
Acquisition of property and businesses	(11,476)	0
Costs incurred for purchase and implementation of electronic health records application	(28,008)	(11,416)
Return of deposit on terminated purchase agreement	6,500	0
Net cash used in investing activities	(161,874)	(125,615)
Cash Flows from Financing Activities:
Reduction of long-term debt	(195,686)	(200,566)
Additional borrowings	0	36,000
Financing costs	0	(23,534)
Repurchase of common shares	(2,927)	(6,163)
Dividends paid	(9,673)	(9,763)
Issuance of common stock	2,575	2,408
Profit distributions to noncontrolling interests	(13,565)	(23,201)
Net cash (used in) provided by financing activities	(219,276)	(224,819)
(Decrease) increase in cash and cash equivalents	(8,288)	5,342
Cash and cash equivalents, beginning of period	41,229	29,474
Cash and cash equivalents, end of period	32,941	34,816
Supplemental Disclosures of Cash Flow Information:
Interest paid	62,158	102,213
Income taxes paid, net of refunds	$ 141,571	$ 83,532

General

6 Months Ended

Jun. 30, 2012

General

(1) General

This Quarterly Report on Form 10-Q is for the quarterly period ended June 30, 2012. In this Quarterly Report, “we,” “us,” “our” and the “Company” refer to Universal Health Services, Inc. and its subsidiaries.

The condensed consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships and limited liability companies controlled by us, or our subsidiaries, as managing general partner or managing member. The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly state results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements, significant accounting policies and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2011.

Relationship with Universal Health Realty Income Trust and Related Party Transactions

6 Months Ended

Jun. 30, 2012

Relationship with Universal Health Realty Income Trust and Related Party Transactions

(2) Relationship with Universal Health Realty Income Trust and Related Party Transactions

Relationship with Universal Health Realty Income Trust:

At June 30, 2012, we held approximately 6.2% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying condensed consolidated statements of income, of $520,000 and $480,000 during the three-month periods ended June 30, 2012 and 2011, respectively and $1.0 million and $951,000 during the six-month periods ended June 30, 2012 and 2011, respectively. Our pre-tax share of income from the Trust was $591,000 and $260,000 for the three-month periods ended June 30, 2012 and 2011, respectively, and $891,000 and $560,000 for the six-month periods ended June 30, 2012 and 2011, respectively. The carrying value of this investment was $9.0 million and $9.9 million at June 30, 2012 and December 31, 2011, respectively, and is included in other assets in the accompanying condensed consolidated balance sheets. The market value of this investment, based on the closing price of the Trust’s stock on the respective dates, was $32.7 million at June 30, 2012 and $30.7 million at December 31, 2011.

Total rent expense under the operating leases on the hospital facilities with the Trust was $4.1 million during each of the three-month periods ended June 30, 2012 and 2011, and $8.2 million and $8.3 million for the six-month periods ended June 30, 2012 and 2011, respectively. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds either 100% ownership interests or non-controlling majority ownership interests.

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust, giving effect to the above-mentioned renewals:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Other Related Party Transactions:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums and certain trusts, owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2011 or the first six months of 2012.

In connection with the commencement of Marvin G. Pember’s employment with us in August, 2011 as Senior Vice President and President of our Acute Care division, we agreed to purchase his former personal residence located in Indiana if it remained unsold to a third-party for longer than 180 days after commencement of his employment. Since the property remained unsold, the purchase occurred in June, 2012 for approximately $1 million which represents the fair-market value as derived by third-party appraisals. We are actively marketing the property for sale to a third-party buyer.

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our Chief Executive Officer (“CEO”) and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph b
-Article 3A

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph k
-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 57
-Paragraph 1-4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

6 Months Ended

Jun. 30, 2012

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

(3) Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves, pension liability, and interest rate swaps.

Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania. The redeemable noncontrolling interest balances of $227 million and $218 million as of June 30, 2012 and December 31, 2011, respectively, and the noncontrolling interest balances of $53 million and $51 million at June 30, 2012 and December 31, 2011, respectively, consist primarily of the third-party ownership interests in these hospitals.

In connection with the five acute care facilities located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights”, that are currently exercisable, that if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with the behavioral health care facility located in Philadelphia, Pennsylvania, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value. As of June 30, 2012, we believe the fair market value of the minority ownership interests in these facilities approximates the book value of the redeemable noncontrolling interests.

Long-term debt and cash flow hedges

6 Months Ended

Jun. 30, 2012

Long-term debt and cash flow hedges

(4) Long-term debt and cash flow hedges

Debt:

On November 15, 2010, we entered into a credit agreement (the “Credit Agreement”) with various financial institutions. The Credit Agreement is a senior secured facility which provided an initial aggregate commitment amount of $3.45 billion, comprised of a new $800 million revolving credit facility, a $1.05 billion Term Loan A facility and a $1.6 billion Term Loan B facility. Prior to the effectiveness of the Credit Agreement Amendment in March, 2011 (as discussed below), we prepaid the principal amount and permanently reduced the Term Loan B commitment by $125 million. During the first six months of 2012, we made scheduled principal payments of $36 million on the Term Loan A and $13 million on the Term Loan B. The revolving credit facility and the Term Loan A mature on November 15, 2015 and the Term Loan B matures on November 15, 2016. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by substantially all of the assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

On March 15, 2011, we entered into a first amendment to the Credit Agreement (the “Amendment”) which became effective immediately and provides, among other things, for a reduction in the interest rates payable in connection with borrowings under the Credit Agreement. Upon the effectiveness of the Amendment, borrowings under the Credit Agreement bear interest at the ABR rate which is defined as the rate per annum equal to, at our election (1) the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month Eurodollar rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit and Term Loan A borrowings and 1.75% to 2.00% for Term Loan B borrowings or (2) the one, two, three or six month Eurodollar rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit and Term Loan A borrowings and ranging from 2.75% to 3.00% for Term Loan B borrowings. The current applicable margins are 0.75% for ABR-based loans, 1.75% for Eurodollar-based loans under the revolving credit and Term Loan A facilities and 2.75% under the Term Loan B facility. Upon the effectiveness of the Amendment, the minimum Eurodollar rate for the Term Loan B facility was reduced from 1.50% to 1.00%. In connection with the Amendment, we paid a fee of 1.00% of the amounts outstanding under the Term Loan B in accordance with the terms of the Credit Agreement.

As of June 30, 2012, we had $623 million of available borrowing capacity pursuant to the terms of our Credit Agreement, net of $115 million of outstanding borrowings and $62 million of outstanding letters of credit.

In October, 2010, we amended our accounts receivable securitization program (“Securitization”) with a group of conduit lenders and liquidity banks. We increased the size of the Securitization to $240 million (the “Commitments”), from $200 million, and extended the maturity date to October 25, 2013. In May, 2012, we further increased the size of the securitization by $35 million to $275 million. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. The interest rate on the borrowings is based on the commercial paper rate plus a spread of 0.475% and there is a facility fee of 0.375% required on 102% on the Commitments. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At June 30, 2012, we had $230 million of outstanding borrowings and $45 million of additional capacity pursuant to the terms of our accounts receivable securitization program.

As of June 30, 2012, we had no outstanding borrowings under a short-term, on-demand credit facility. When applicable, outstanding borrowings pursuant to this facility are classified as long-term debt on our Consolidated Balance Sheet since we have the intent and ability to refinance through available borrowings under the terms of our Credit Agreement.

On September 29, 2010, we issued $250 million of 7.00% senior unsecured notes (the “Unsecured Notes”) which are scheduled to mature on October 1, 2018. The Unsecured Notes were registered in April, 2011. Interest on the Unsecured Notes is payable semiannually in arrears on April 1st and October 1st of each year. The Unsecured Notes can be redeemed in whole at anytime subject to a make-whole call at treasury rate plus 50 basis points prior to October 1, 2014. They are also redeemable in whole or in part at a price of: (i) 103.5% on or after October 1, 2014; (ii) 101.75% on or after October 1, 2015, and; (iii) 100% on or after October 1, 2016. These Unsecured Notes are guaranteed by a group of subsidiaries (each of which is a 100% directly owned subsidiary of Universal Health Services, Inc.) which fully and unconditionally guarantee the Unsecured Notes on a joint and several basis, subject to certain customary automatic release provisions.

On June 30, 2006, we issued $250 million of senior notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

In connection with the entering into of the Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates and dividends; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of June 30, 2012.

The carrying amount and fair value of our debt was $3.46 billion and $3.53 billion at June 30, 2012, respectively. The fair value of our debt was computed based upon quotes received from financial institutions and we consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

Cash Flow Hedges:

We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within stockholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods in which the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the changes in expected cash flows of the hedged item are recognized currently in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness and consideration of nonperformance risk of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2011 and the first six months of 2012 and determined the hedges to be highly effective. We also determined that no significant portion of the hedges is ineffective as of June 30, 2012. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. We do not anticipate nonperformance by our counterparties. At June 30, 2012, each swap agreement entered into by us was in a net liability position which would require us to make the net settlement payments to the counterparties. We do not hold or issue derivative financial instruments for trading purposes.

During the first quarter of 2011, we entered into a forward starting interest rate cap on a total notional amount of $450 million from December, 2011 to December, 2012 reducing to $400 million from December, 2012 to December, 2013 whereby we paid a premium of $740,000 in exchange for the counterparty agreeing to pay the difference between 7.00% and three-month LIBOR if the three-month LIBOR rate rises above 7.00% during the term of the cap. If the three-month LIBOR does not reach 7.00% during the term of the cap, no payment is made to us.

We also entered into six forward starting interest rate swaps in the first quarter of 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $100 million, $25 million and $75 million became effective in December, 2011 and have fixed rates of 2.50%, 1.96% and 1.32%, and maturity dates in December, 2014, December, 2013 and December, 2012, respectively.

During the fourth quarter of 2010, we entered into four forward starting interest rate swaps whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%.

During the fourth quarter of 2007, we entered into an interest rate swap whereby we pay a fixed rate on a total notional principal amount of $75 million and receive three-month LIBOR. The fixed rate payable is 4.76% and it matures in October, 2012.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was a liability of $46 million at June 30, 2012, of which $1 million is included in other current liabilities and $45 million is included in other noncurrent liabilities on the accompanying balance sheet.

Commitments and Contingencies

6 Months Ended

Jun. 30, 2012

Commitments and Contingencies

(5) Commitments and Contingencies

Professional and General Liability Claims and Property Insurance

Professional and General Liability

Effective January 1, 2008, most of our subsidiaries became self-insured for professional and general liability exposure up to $10 million per occurrence. Prior to our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, our subsidiaries purchased several excess policies through commercial insurance carriers which provide for coverage in excess of $10 million up to $200 million per occurrence and in the aggregate. However, we are liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate.

Prior to our acquisition in November, 2010, the PSI subsidiaries were commercially insured for professional and general liability insurance claims in excess of a $3 million self-insured retention to a limit of $75 million. PSI utilized its captive insurance company and that captive insurance company remains in place after our acquisition of PSI to manage the self-insured retention for all former PSI subsidiaries for claims incurred prior to January 1, 2011. The captive insurance company also continues to manage the applicable self-insured retention for all professional and general liability claims, regardless of date incurred, for the former PSI subsidiaries located in Florida and Puerto Rico.

Since our acquisition of PSI on November 15, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence and our legacy subsidiaries (which are not former PSI subsidiaries) are self-insured for professional and general liability exposure up to $10 million per occurrence. Effective November, 2010, our subsidiaries (including the former PSI subsidiaries) were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $200 million per occurrence and in the aggregate. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

As of June 30, 2012 and December 31, 2011, the total accrual for our professional and general liability claims, including the estimated claims related to the facilities acquired from PSI, was $288 million and $292 million, respectively, of which $60 million is included in current liabilities as of each date.

Property Insurance

We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible for the majority of our properties (the properties acquired from Psychiatric Solutions, Inc. are subject to a $50,000 deductible). Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million. Flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility.

Other

As of June 30, 2012 and December 31, 2011, our accounts receivable includes approximately $72 million and $54 million, respectively, due from Illinois. Collection of these receivables continues to be delayed due to state budgetary and funding pressures. Approximately $52 million as of June 30, 2012, and $41 million as of December 31, 2011, of the receivables due from Illinois have been outstanding in excess of 60 days, as of each respective date, and a large portion will likely remain outstanding for the foreseeable future. Since we expect to eventually collect all amounts due to us, no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois. Failure to ultimately collect all outstanding amounts due from Illinois would have an adverse impact on our future consolidated results of operations and cash flows.

As of June 30, 2012, we were party to certain off balance sheet arrangements consisting of standby letters of credit and surety bonds which totaled $81 million consisting of: (i) $65 million related to our self-insurance programs, and; (ii) $16 million of other debt and public utility guarantees.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to litigation, as outlined below.

Martin v. UHS of Delaware:

UHS of Delaware, Inc., a wholly-owned subsidiary of ours, has been named as defendants in a state False Claim Act case in Sacramento County Superior Court. Plaintiffs are a former student and employees of the Elmira School who claim that the UHS schools in California unlawfully retained public education funding from the state of California for the operation of these schools but failed to meet state requirements pertaining to the operation of non-public schools. During the second quarter of 2012, we reached a settlement in connection with this matter which requires finalization of a definitive agreement which is subject to approval of the California Attorney General’s Office and Superior Court presiding over the case. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

Department of Justice ICD Investigation:

In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice (“DOJ”) advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) from 2003 to the present at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Claims Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

Two Rivers Psychiatric Hospital:

In April, 2011, the Centers for Medicare and Medicaid Services (“CMS”) issued notice of its decision terminating Two Rivers Psychiatric Hospital (“Two Rivers”) in Kansas City, Missouri from participation in the Medicare and Medicaid program. The termination notice was issued as a result of surveys conducted which allegedly found Two Rivers to be out of compliance with the conditions of participation required for participation in the Medicare program and for Two Rivers’ alleged failure to alleviate an “immediate jeopardy” situation. Two Rivers filed an administrative appeal with the U.S. Department of Health and Human Services, Departmental Appeal Board, Civil Remedies Division, seeking review and reversal of that decision. In addition, Two Rivers filed a complaint in the U.S. District Court for the Western District of Missouri seeking a temporary restraining order and preliminary injunction against CMS rescinding the termination action. Later in April, 2011, the District Court issued a temporary restraining order abating the termination action pending a preliminary injunction hearing or an agreement with CMS. In May, 2011, Two Rivers and CMS entered into a settlement agreement which resulted in the rescission of the termination notice and actions by CMS. Pursuant to the terms of the agreement, Two Rivers was required to submit an acceptable plan of correction relative to the immediate jeopardy citation and engage independent experts in various disciplines to analyze and develop implementation plans for Two Rivers to meet the applicable Medicare conditions of participation. Both of these actions have occurred. Pursuant to the agreement, CMS conducted an initial survey of Two Rivers in April 2012 to determine if the Medicare conditions of participation, which formed the basis of the termination action in April 2011, have been met. In late April, 2012, CMS advised Two Rivers that it has successfully passed this initial survey. Pursuant to the terms of the agreement, a second survey will be conducted either late 2012 or early 2013 to further confirm that Two Rivers is in compliance with all Medicare/Medicaid Conditions of Participation. During the term of this agreement, Two Rivers remains eligible to receive reimbursements for services rendered to Medicare and Medicaid beneficiaries. Two Rivers remains fully committed to providing high-quality healthcare to their patients and the community it serves. We therefore intend to work expeditiously and collaboratively with CMS in an effort to resolve these matters. We can provide no assurance that Two Rivers will not ultimately lose its Medicare certification. The operating results of Two Rivers did not have a material impact on our consolidated results of operations or financial condition for the six-month period ended June 30, 2012 or the year ended December 31, 2011.

Office of Inspector General Investigation of Peachford Hospital:

In July, 2012, one of our subsidiaries, Peachford Behavioral Health System of Atlanta located in Atlanta, Georgia, received a subpoena from the Office of the Inspector General for the Department of Health and Human Services requesting various documents from 2004 to the present. We are in the process of securing and collecting the requested documents for production. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Matters Relating to PSI:

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of Psychiatric Solutions, Inc.) for which we have assumed the defense as a result of our acquisition of PSI which was completed in November, 2010:

Garden City Employees’ Retirement System v. PSI:

This is a purported shareholder class action lawsuit filed in the United States District Court for the Middle District of Tennessee against PSI and the former directors in 2009 alleging violations of federal securities laws. We intend to defend the case vigorously. Should we be deemed liable in this matter, we believe we would be entitled to commercial insurance recoveries for amounts paid by us, subject to certain limitations and deductibles. Included in our consolidated balance sheets as of June 30, 2012 and December 31, 2011, is an estimated reserve (current liability) and corresponding commercial insurance recovery (current asset) which did not have a material impact on our financial statements. Although we believe the commercial insurance recoveries are adequate to satisfy potential liability and related legal fees in connection with this matter, we can provide no assurance that the ultimate liability will not exceed the commercial insurance recoveries which would make us liable for the excess.

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents have been collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July 2011 requesting additional documents, a portion of which have been collected and delivered to the DOJ, pursuant to their request. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ and we continue to cooperate with the DOJ with respect to this investigation. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Virginia Department of Medical Assistance Services Recoupment Claims:

The Virginia Department of Medical Assistance Services (“DMAS”) has conducted audits at seven former PSI Residential Treatment Centers operated in the Commonwealth of Virginia to confirm compliance with provider rules under the state’s Medicaid Provider Services Manual (“Manual”). As a result of those audits, DMAS claims the facilities failed to comply with the requirements of the Manual and has requested repayment of Medicaid payments to those facilities. PSI had previously filed appeals to repayment demands at each facility which are currently pending. The aggregate refund of Medicaid payments made to those facilities, as requested by DMAS, and the corresponding reserve established on our consolidated balance sheet, was not material to our consolidated financial position or results of operations.

General:

The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Segment Reporting

6 Months Ended

Jun. 30, 2012

Segment Reporting

(6) Segment Reporting

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of the Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents of each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2011. The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment, to the extent possible, with the non-directly allocated overhead expenses allocated based upon each segment’s respective percentage of total facility-based operating expenses.


	Three months ended June 30, 2012
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,034,837		$	1,423,894			—		$	4,458,731
Gross outpatient revenues	$	1,540,569		$	162,475		$	12,723		$	1,715,767
Total net revenues	$	845,552		$	875,031		$	9,220		$	1,729,803
Income/(loss) before allocation of corporate overhead and income taxes	$	61,602		$	224,963		($	102,121	)	$	184,444
Allocation of corporate overhead		($37,979	)		($21,071	)	$	59,050			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	23,623		$	203,892			($43,071	)	$	184,444
Total assets as of 6/30/12	$	2,957,192		$	4,431,758		$	369,698		$	7,758,648


	Six months ended June 30, 2012
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,312,862		$	2,845,979			—		$	9,158,841
Gross outpatient revenues	$	3,089,419		$	323,733		$	24,993		$	3,438,145
Total net revenues	$	1,772,083		$	1,739,904		$	15,405		$	3,527,392
Income/(loss) before allocation of corporate overhead and income taxes	$	191,450		$	427,459		($	212,147	)	$	406,762
Allocation of corporate overhead		($78,722	)		($42,132	)	$	120,854			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	112,728		$	385,327			($91,293	)	$	406,762
Total assets as of 6/30/12	$	2,957,192		$	4,431,758		$	369,698		$	7,758,648

	Three months ended June 30, 2011
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	2,951,260		$	1,404,643			—		$	4,355,903
Gross outpatient revenues	$	1,364,531		$	157,748		$	14,671		$	1,536,950
Total net revenues	$	863,907		$	844,734		$	5,823		$	1,714,464
Income/(loss) before allocation of corporate overhead and income taxes	$	91,145		$	189,590			($98,306	)	$	182,429
Allocation of corporate overhead		($30,518	)		($15,691	)	$	46,209			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	60,627		$	173,899			($52,097	)	$	182,429
Total assets as of 6/30/11	$	2,779,803		$	4,381,320		$	404,630		$	7,565,753

	Six months ended June 30, 2011
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,107,084		$	2,795,844			—		$	8,902,928
Gross outpatient revenues	$	2,684,482		$	307,343		$	27,540		$	3,019,365
Total net revenues	$	1,755,295		$	1,673,678		$	11,749		$	3,440,722
Income/(loss) before allocation of corporate overhead and income taxes	$	218,129		$	375,378			($207,082	)	$	386,425
Allocation of corporate overhead		($63,324	)		($31,416	)	$	94,740			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	154,805		$	343,962		($	112,342	)	$	386,425
Total assets as of 6/30/11	$	2,779,803		$	4,381,320		$	404,630		$	7,565,753

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation

6 Months Ended

Jun. 30, 2012

Earnings Per Share Data ("EPS") and Stock Based Compensation

(7) Earnings Per Share Data (“EPS”) and Stock Based Compensation

Basic earnings per share are based on the weighted average number of common shares outstanding during the period. Diluted earnings per share are based on the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended June 30,						Six months ended June 30,
	(amounts in thousands)
	2012			2011			2012			2011
Basic and Diluted:
Net income attributable to UHS	$	107,561		$	103,649		$	236,168		$	217,842
Less: Net income attributable to unvested restricted share grants		(126	)		(126	)		(294	)		(275	)

Net income attributable to UHS—basic and diluted	$	107,435		$	103,523		$	235,874		$	217,567

Weighted average number of common shares—basic		96,691			97,563			96,642			97,472
Net effect of dilutive stock options and grants based on the treasury stock method		1,038			1,695			1,118			1,591

Weighted average number of common shares and equivalents—diluted		97,729			99,258			97,760			99,063

Earnings per basic share attributable to UHS:	$	1.11		$	1.06		$	2.44		$	2.23

Earnings per diluted share attributable to UHS:	$	1.10		$	1.04		$	2.41		$	2.20

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all periods presented above, excludes certain outstanding stock options applicable to each period since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 2.6 million for each of the three months and six months ended June 30, 2012. There were no significant anti-dilutive stock options during the three and six months ended June 30, 2011. All classes of our common stock have the same dividend rights.

Stock-Based Compensation: During the three-month periods ended June 30, 2012 and 2011, compensation cost of $4.7 million ($2.9 million after-tax) and $4.2 million ($2.6 million after-tax), respectively, was recognized related to outstanding stock options. During the six-month periods ended June 30, 2012 and 2011, compensation cost of $9.6 million ($6.0 million after-tax) and $7.7 million ($4.7 million after-tax), respectively, was recognized related to outstanding stock options. In addition, during the three-month periods ended June 30, 2012 and 2011, compensation cost of approximately $593,000 ($369,000 after-tax) and $455,000 ($281,000 after-tax), respectively, was recognized related to restricted stock. During the six-month periods ended June 30, 2012 and 2011, compensation cost of approximately $1.2 million ($727,000 after-tax) and $906,000 ($559,000 after-tax), respectively, was recognized related to restricted stock. As of June 30, 2012 there was $45.3 million of unrecognized compensation cost related to unvested options and restricted stock which is expected to be recognized over the remaining weighted average vesting period of 2.9 years. There were 2,870,200 stock options granted (net of cancellations) during the first six months of 2012 with a weighted-average grant date fair value of $10.72 per share. There were 54,127 restricted stock shares granted during the first six months of 2012, with a weighted-average grant date fair value of $36.95 per share.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Dispositions and acquisitions

6 Months Ended

Jun. 30, 2012

Dispositions and acquisitions

(8) Dispositions and acquisitions

Six-month period ended June 30, 2012:

Acquisitions:

In June, 2012, we executed a definitive agreement to acquire Ascend Health Corporation (“Ascend”) for $500 million in cash. Including the assumption of $17 million in Ascend net debt, the total transaction consideration is approximately $517 million. Ascend is the largest private psychiatric hospital provider with 9 owned or leased freestanding psychiatric inpatient facilities located in 5 states including Texas, Arizona, Utah, Oregon and Washington. We expect to complete the transaction in the fourth quarter of 2012, subject to customary closing conditions, including regulatory approvals and clearance under the Hart-Scott-Rodino Act.

During the first six months of 2012, we spent $11 million in connection with the acquisition of a physician practice and various real properties.

As a result of the third-party seller’s inability to obtain the removal of the deed restriction on its hospital, we provided the seller with a notice of termination of the previously executed purchase agreement in connection with our planned acquisition of the Knapp Medical Center located in Weslaco, Texas. In connection with this termination, our $6.5 million deposit was refunded to us in March, 2012.

Divestitures:

During the first six months of 2012, we received aggregate cash proceeds of approximately $53 million for the divestiture of: (i) the Hospital San Juan Capestrano, a 108-bed behavioral health care facility located in Rio Piedras, Puerto Rico, that was sold in January, 2012 pursuant to our agreement with the Federal Trade Commission in connection with our acquisition of Psychiatric Solutions, Inc., and; (ii) the real property of a previously closed behavioral health care facility. The pre-tax net gain on these divestitures did not have a material impact on our consolidated results of operations during the first six months of 2012. The assets and liabilities for the Hospital San Juan Capestrano were reflected as “held for sale” on our Consolidated Balance Sheet as of December 31, 2011.

In addition, we executed a definitive agreement to sell Auburn Regional Medical Center, a 213-bed acute care hospital located in Auburn, Washington, for total cash proceeds of approximately $98 million including estimated working capital. The transaction, which is subject to customary regulatory approvals, is expected to occur by the end of the third quarter of 2012. We expect to realize a substantial gain on the divestiture of this hospital which will be recorded in our consolidated financial statements upon closing of the transaction. The operating results for Auburn Regional Medical Center are reflected as discontinued operations for each of the periods presented herein. Since the hospital’s income/loss before income taxes is not material to our consolidated financial statements it is included in other operating expenses. The assets and liabilities for Auburn Regional Medical Center are reflected as “held for sale” on our Consolidated Balance Sheet as of June 30, 2012.

Six-month period ended June 30, 2011:

Acquisitions:

There were no acquisitions during the first six months of 2011.

Divestitures:

During the first six months of 2011, we received cash proceeds of $2 million for: (i) sale of the real property of a closed acute care hospital (during first quarter), and; (ii) installment payment for our ownership interest in an outpatient surgery center (during second quarter). These transactions did not have a material impact on our consolidated financial statements or results of operations.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 88-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51, 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 67-73
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Dividends	6 Months Ended
Dividends	Jun. 30, 2012
Dividends	(9) Dividends We declared and paid dividends of $4.8 million, or $.05 per share, during the second quarter of 2012 and $4.9 million, or $.05 per share, during the second quarter of 2011. We declared and paid dividends of $9.7 million and $9.8 million during the six-month periods ended June 30, 2012 and 2011, respectively.

Pension Plan

6 Months Ended

Jun. 30, 2012

Pension Plan

(10) Pension Plan

The following table shows the components of net periodic pension cost for our defined benefit pension plan as of June 30, 2012 and 2011 (amounts in thousands):


	Three months ended June 30,						Six months ended June 30,
	2012			2011			2012			2011
Service cost	$	286		$	247		$	572		$	581
Interest cost		1,165			1,071			2,330			2,523
Expected return on assets		(2,111	)		(1,774	)		(3,651	)		(3,283	)
Recognized actuarial loss		1,055			470			2,110			1,214

Net periodic pension cost	$	395		$	14		$	1,361		$	1,035

During the six months ended June 30, 2012, we made contributions totaling $7.1 million to our pension plan.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Implementation Guide (Q and A)
-Number FAS88
-Paragraph 63
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-2
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph q
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 8
-Subparagraph m
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS106-2
-Paragraph 20, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 30
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Income Taxes

6 Months Ended

Jun. 30, 2012

Income Taxes

(11) Income Taxes

As of January 1, 2012, our unrecognized tax benefits were approximately $7 million. The amount, if recognized, that would affect the effective tax rate is approximately $5 million. During the quarter ended June 30, 2012, changes to the estimated liabilities for uncertain tax positions (including accrued interest) relating to tax positions taken during prior and current periods did not have a material impact on our financial statements.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of June 30, 2012, we have approximately $1 million of accrued interest and penalties. The U.S. federal statute of limitations remains open for the 2008 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging from 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Supplemental Condensed Consolidating Financial Information

6 Months Ended

Jun. 30, 2012

Supplemental Condensed Consolidating Financial Information

(12) Supplemental Condensed Consolidating Financial Information

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non-guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non-guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,295,803		$	625,213		$	(6,553	)	$	1,914,463
Less: Provision for doubtful accounts		0			105,390			79,270			0			184,660

Net revenues		0			1,190,413			545,943			(6,553	)		1,729,803


Operating charges:
Salaries, wages and benefits		0			608,937			247,941			0			856,878
Other operating expenses		0			223,553			130,318			(6,459	)		347,412
Supplies expense		0			122,524			75,576			0			198,100
Depreciation and amortization		0			50,997			22,081			0			73,078
Lease and rental expense		0			14,394			9,703			(94	)		24,003

		0			1,020,405			485,619			(6,553	)		1,499,471


Income from operations		0			170,008			60,324			0			230,332
Interest expense		44,298			838			752			0			45,888
Interest (income) expense, affiliate		0			22,783			(22,783	)		0			0
Equity in net income of consolidated affiliates		(134,904	)		(28,548	)		0			163,452			0

Income before income taxes		90,606			174,935			82,355			(163,452	)		184,444
Provision for income taxes		(16,955	)		62,521			21,434			0			67,000

Net income		107,561			112,414			60,921			(163,452	)		117,444
Less: Income attributable to noncontrolling interests		0			0			9,883			0			9,883

Net income attributable to UHS	$	107,561		$	112,414		$	51,038		$	(163,452	)	$	107,561

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,629,267		$	1,244,287		$	(12,879	)	$	3,860,675
Less: Provision for doubtful accounts		0			194,768			138,515			0			333,283

Net revenues		0			2,434,499			1,105,772			(12,879	)		3,527,392


Operating charges:
Salaries, wages and benefits		0			1,229,795			501,077			0			1,730,872
Other operating expenses		0			459,587			254,088			(12,690	)		700,985
Supplies expense		0			250,833			152,907			0			403,740
Depreciation and amortization		0			102,256			42,714			0			144,970
Lease and rental expense		0			29,238			18,416			(189	)		47,465

		0			2,071,709			969,202			(12,879	)		3,028,032


Income from operations		0			362,790			136,570			0			499,360
Interest expense		89,452			1,625			1,521			0			92,598
Interest (income) expense, affiliate		0			45,565			(45,565	)		0			0
Equity in net income of consolidated affiliates		(291,382	)		(69,625	)		0			361,007			0

Income before income taxes		201,930			385,225			180,614			(361,007	)		406,762
Provision for income taxes		(34,238	)		136,629			44,357			0			146,748

Net income		236,168			248,596			136,257			(361,007	)		260,014
Less: Income attributable to noncontrolling interests		0			0			23,846			0			23,846

Net income attributable to UHS	$	236,168		$	248,596		$	112,411		$	(361,007	)	$	236,168

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,265,907		$	609,853		$	(6,346	)	$	1,869,414
Less: Provision for doubtful accounts		0			80,327			74,623			0			154,950

Net revenues		0			1,185,580			535,230			(6,346	)		1,714,464


Operating charges:
Salaries, wages and benefits		0			597,724			238,835			0			836,559
Other operating expenses		0			236,064			119,641			(6,251	)		349,454
Supplies expense		0			126,185			75,818			0			202,003
Depreciation and amortization		0			51,088			20,127			0			71,215
Lease and rental expense		0			15,325			7,766			(95	)		22,996

		0			1,026,386			462,187			(6,346	)		1,482,227


Income from operations		0			159,194			73,043			0			232,237
Interest expense, net		48,386			809			613			0			49,808
Interest (income) expense, affiliate		0			15,904			(15,904	)		0			0
Equity in net income of consolidated affiliates		(133,832	)		(38,049	)		0			171,881			0

Income before income taxes		85,446			180,530			88,334			(171,881	)		182,429
Provision for income taxes		(18,203	)		65,171			19,427			0			66,395

Net income		103,649			115,359			68,907			(171,881	)		116,034
Less: Income attributable to noncontrolling interests		0			0			12,385			0			12,385

Net income attributable to UHS	$	103,649		$	115,359		$	56,522		$	(171,881	)	$	103,649

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,550,935		$	1,206,560		$	(12,653	)	$	3,744,842
Less: Provision for doubtful accounts		0			170,756			133,364			0			304,120

Net revenues		0			2,380,179			1,073,196			(12,653	)		3,440,722


Operating charges:
Salaries, wages and benefits		0			1,190,926			476,391			0			1,667,317
Other operating expenses		0			467,052			234,222			(12,463	)		688,811
Supplies expense		0			253,889			151,393			0			405,282
Depreciation and amortization		0			101,721			39,088			0			140,809
Lease and rental expense		0			30,995			15,048			(190	)		45,853

		0			2,044,583			916,142			(12,653	)		2,948,072


Income from operations		0			335,596			157,054			0			492,650
Interest expense, net		103,256			1,602			1,367			0			106,225
Interest (income) expense, affiliate		0			31,808			(31,808	)		0			0
Equity in net income of consolidated affiliates		(281,440	)		(88,251	)		0			369,691			0

Income before income taxes		178,184			390,437			187,495			(369,691	)		386,425
Provision for income taxes		(39,658	)		140,132			39,930			0			140,404

Net income		217,842			250,305			147,565			(369,691	)		246,021
Less: Income attributable to noncontrolling interests		0			0			28,179			0			28,179

Net income attributable to UHS	$	217,842		$	250,305		$	119,386		$	(369,691	)	$	217,842

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	107,561		$	112,414	$	60,921	$	(163,452	)	$	117,444
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		212			0		0		0			212
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		128			0		0		0			128
Income tax expense related to items of other comprehensive income		50			0		0		0			50

Total other comprehensive income, net of tax		78			0		0		0			78


Comprehensive income		107,639			112,414		60,921		(163,452	)		117,522
Less: Comprehensive income attributable to noncontrolling interests		0			0		9,883		0			9,883

Comprehensive income attributable to UHS	$	107,639		$	112,414	$	51,038	$	(163,452	)	$	107,639

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	236,168		$	248,596	$	136,257	$	(361,007	)	$	260,014
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		1,827			0		0		0			1,827
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		1,659			0		0		0			1,659
Income tax expense related to items of other comprehensive income		632			0		0		0			632

Total other comprehensive income, net of tax		1,027			0		0		0			1,027


Comprehensive income		237,195			248,596		136,257		(361,007	)		261,041
Less: Comprehensive income attributable to noncontrolling interests		0			0		23,846		0			23,846

Comprehensive income attributable to UHS	$	237,195		$	248,596	$	112,411	$	(361,007	)	$	237,195

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	103,649		$	115,359	$	68,907	$	(171,881	)	$	116,034
Other comprehensive income (loss):
Unrealized derivative losses on cash flow hedges		(20,583	)		0		0		0			(20,583	)
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		(20,667	)		0		0		0			(20,667	)
Income tax expense related to items of other comprehensive income		(7,916	)		0		0		0			(7,916	)

Total other comprehensive income, net of tax		(12,751	)		0		0		0			(12,751	)


Comprehensive income		90,898			115,359		68,907		(171,881	)		103,283
Less: Comprehensive income attributable to noncontrolling interests		0			0		12,385		0			12,385

Comprehensive income attributable to UHS	$	90,898		$	115,359	$	56,522	$	(171,881	)	$	90,898

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	217,842		$	250,305	$	147,565	$	(369,691	)	$	246,021
Other comprehensive income (loss):
Unrealized derivative losses on cash flow hedges		(18,276	)		0		0		0			(18,276	)
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		(18,444	)		0		0		0			(18,444	)
Income tax expense related to items of other comprehensive income		(7,056	)		0		0		0			(7,056	)

Total other comprehensive income, net of tax		(11,388	)		0		0		0			(11,388	)


Comprehensive income		206,454			250,305		147,565		(369,691	)		234,633
Less: Comprehensive income attributable to noncontrolling interests		0			0		28,179		0			28,179

Comprehensive income attributable to UHS	$	206,454		$	250,305	$	119,386	$	(369,691	)	$	206,454

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF JUNE 30, 2012

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	23,148		$	9,793		$	0		$	32,941
Accounts receivable, net		3,786		705,845			310,298			0			1,019,929
Supplies		0		58,738			38,144			0			96,882
Other current assets		12,878		77,560			9,096			0			99,534
Deferred income taxes		81,565		41,230			322			(322	)		122,795
Current assets held for sale		0		84,365			0			0			84,365

Total current assets		98,229		990,886			367,653			(322	)		1,456,446

Investments in subsidiaries		5,504,955		1,251,474			0			(6,756,429	)		0
Intercompany receivable		475,833		0			129,403			(605,236	)		0
Intercompany note receivable		0		0			1,142,539			(1,142,539	)		0
Property and equipment		0		3,687,805			1,484,602			0			5,172,407
Less: accumulated depreciation		0		(1,205,261	)		(670,231	)		0			(1,875,492	)

		0		2,482,544			814,371			0			3,296,915

Other assets:
Goodwill		820		2,115,465			494,352			0			2,610,637
Deferred charges		91,728		5,986			8,381			0			106,095
Other		9,450		192,612			86,493			0			288,555

	$	6,181,015	$	7,038,967		$	3,043,192		$	(8,504,526	)	$	7,758,648


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,049		$	1,448		$	0		$	2,497
Accounts payable and accrued liabilities		27,519		620,332			204,405			0			852,256
Current liabilities held for sale		0		15,966			0			0			15,966
Federal and state taxes		12,072		201			620			0			12,893

Total current liabilities		39,591		637,548			206,473			0			883,612

Intercompany payable		0		605,236			0			(605,236	)		0
Other noncurrent liabilities		50,747		237,291			105,890			0			393,928
Long-term debt		3,405,069		1,411			52,029			0			3,458,509
Intercompany note payable		0		1,142,539			0			(1,142,539	)		0
Deferred income taxes		148,724		58,001			0			(322	)		206,403
Redeemable noncontrolling interests		0		0			226,537			0			226,537
UHS common stockholders’ equity		2,536,884		4,356,941			2,399,488			(6,756,429	)		2,536,884
Noncontrolling interest		0		0			52,775			0			52,775

Total equity		2,536,884		4,356,941			2,452,263			(6,756,429	)		2,589,659

	$	6,181,015	$	7,038,967		$	3,043,192		$	(8,504,526	)	$	7,758,648

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2011

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Other current assets		33,057		56,864			9,938			0			99,859
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			74,155			(743,267	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0
Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980


Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		743,267			0			(743,267	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592
Redeemable noncontrolling interests		0		0			218,266			0			218,266
UHS common stockholders’ equity		2,296,352		4,108,345			2,287,077			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,108,345			2,337,843			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	2,144		$	279,941		$	90,777		$	0	$	372,862

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(153,894	)		(28,457	)		0		(182,351	)
Proceeds received from sale of assets and businesses		0			49,984			3,477			0		53,461
Acquisition of property and businesses		0			(11,476	)		0					(11,476	)
Costs incurred for purchase and development of electronic health records application		0			(28,008	)		0			0		(28,008	)
Return of deposit on terminated purchase agreement		6,500			0			0			0		6,500

Net cash used in investing activities		6,500			(143,394	)		(24,980	)		0		(161,874	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(191,898	)		(2,289	)		(1,499	)		0		(195,686	)
Repurchase of common shares		(2,927	)		0			0			0		(2,927	)
Dividends paid		(9,673	)		0			0			0		(9,673	)
Issuance of common stock		2,575			0			0			0		2,575
Profit distributions to noncontrolling interests		0			0			(13,565	)		0		(13,565	)
Changes in intercompany balances with affiliates, net		193,279			(144,331	)		(48,948	)		0		0

Net cash (used in) provided by financing activities		(8,644	)		(146,620	)		(64,012	)		0		(219,276	)

Increase (decrease) in cash and cash equivalents		0			(10,073	)		1,785			0		(8,288	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0		41,229

Cash and cash equivalents, end of period	$	0		$	23,148		$	9,793		$	0	$	32,941

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	13,222		$	298,741			43,813		$	0	$	355,776


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(88,240	)		(28,000	)		0		(116,240	)
Proceeds received from sale of assets and businesses		0			2,041			0			0		2,041
Costs incurred for purchase and development of electronic health records application		0			(11,416	)		0			0		(11,416	)

Net cash used in investing activities		0			(97,615	)		(28,000	)		0		(125,615	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(188,161	)		(850	)		(11,555	)		0		(200,566	)
Additional borrowings		36,000			0			0			0		36,000
Financing costs		(23,534	)		0			0			0		(23,534	)
Repurchase of common shares		(6,163	)		0			0			0		(6,163	)
Dividends paid		(9,763	)		0			0			0		(9,763	)
Issuance of common stock		2,408			0			0			0		2,408
Profit distributions to noncontrolling interests		0			0			(23,201	)		0		(23,201	)
Changes in intercompany balances with affiliates, net		175,991			(194,187	)		18,196					0


Net cash (used in) provided by financing activities		(13,222	)		(195,037	)		(16,560	)		0		(224,819	)

Increase (decrease) in cash and cash equivalents		0			6,089			(747	)		0		5,342
Cash and cash equivalents, beginning of period		0			21,385			8,089			0		29,474

Cash and cash equivalents, end of period	$	0		$	27,474 $			7,342		$	0	$	34,816

Recent Accounting Standards

6 Months Ended

Jun. 30, 2012

Recent Accounting Standards

(13) Recent Accounting Standards

Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities: During the first quarter of 2012, we adopted the Financial Accounting Standards Board’s Accounting Standards Update (“ASU”) No. 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which required certain health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). As a result, the provision for doubtful accounts for our acute care and behavioral health care facilities is reflected as a deduction from net revenues in the accompanying consolidated statements of income for the three and six-month periods ended June 30, 2012 and 2011. The adoption of this standard had no impact on our financial position or overall results of operations.

Presentation of Comprehensive Income: In June 2011, the FASB amended its guidance governing the presentation of comprehensive income. The amended guidance eliminates the option to report other comprehensive income and its components in the statement of changes in equity. Under the new guidance, an entity can elect to present items of net income and other comprehensive income in one continuous statement referred to as the statement of comprehensive income or in two separate, but consecutive, statements. While the options for presenting other comprehensive income change under the guidance, other portions of the current guidance will not change. For public entities, these changes are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this standard did not have an impact on our consolidated financial position or results of operations.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6510796

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=6958853&loc=d3e46468-122699

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22580-107794

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 01
-Paragraph b
-Subparagraph 6
-Article 10

+ Details

Relationship with Universal Health Realty Income Trust and Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2012

Renewal Options and Terms for each of Four Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust, giving effect to the above-mentioned renewals:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2012

Segment Reporting

The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment, to the extent possible, with the non-directly allocated overhead expenses allocated based upon each segment’s respective percentage of total facility-based operating expenses.


	Three months ended June 30, 2012
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,034,837		$	1,423,894			—		$	4,458,731
Gross outpatient revenues	$	1,540,569		$	162,475		$	12,723		$	1,715,767
Total net revenues	$	845,552		$	875,031		$	9,220		$	1,729,803
Income/(loss) before allocation of corporate overhead and income taxes	$	61,602		$	224,963		($	102,121	)	$	184,444
Allocation of corporate overhead		($37,979	)		($21,071	)	$	59,050			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	23,623		$	203,892			($43,071	)	$	184,444
Total assets as of 6/30/12	$	2,957,192		$	4,431,758		$	369,698		$	7,758,648


	Six months ended June 30, 2012
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,312,862		$	2,845,979			—		$	9,158,841
Gross outpatient revenues	$	3,089,419		$	323,733		$	24,993		$	3,438,145
Total net revenues	$	1,772,083		$	1,739,904		$	15,405		$	3,527,392
Income/(loss) before allocation of corporate overhead and income taxes	$	191,450		$	427,459		($	212,147	)	$	406,762
Allocation of corporate overhead		($78,722	)		($42,132	)	$	120,854			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	112,728		$	385,327			($91,293	)	$	406,762
Total assets as of 6/30/12	$	2,957,192		$	4,431,758		$	369,698		$	7,758,648

	Three months ended June 30, 2011
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	2,951,260		$	1,404,643			—		$	4,355,903
Gross outpatient revenues	$	1,364,531		$	157,748		$	14,671		$	1,536,950
Total net revenues	$	863,907		$	844,734		$	5,823		$	1,714,464
Income/(loss) before allocation of corporate overhead and income taxes	$	91,145		$	189,590			($98,306	)	$	182,429
Allocation of corporate overhead		($30,518	)		($15,691	)	$	46,209			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	60,627		$	173,899			($52,097	)	$	182,429
Total assets as of 6/30/11	$	2,779,803		$	4,381,320		$	404,630		$	7,565,753

	Six months ended June 30, 2011
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,107,084		$	2,795,844			—		$	8,902,928
Gross outpatient revenues	$	2,684,482		$	307,343		$	27,540		$	3,019,365
Total net revenues	$	1,755,295		$	1,673,678		$	11,749		$	3,440,722
Income/(loss) before allocation of corporate overhead and income taxes	$	218,129		$	375,378			($207,082	)	$	386,425
Allocation of corporate overhead		($63,324	)		($31,416	)	$	94,740			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	154,805		$	343,962		($	112,342	)	$	386,425
Total assets as of 6/30/11	$	2,779,803		$	4,381,320		$	404,630		$	7,565,753

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details

Earnings Per Share Data ("EPS") and Stock Based Compensation (Tables)

6 Months Ended

Jun. 30, 2012

Computation of Basic and Diluted Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended June 30,						Six months ended June 30,
	(amounts in thousands)
	2012			2011			2012			2011
Basic and Diluted:
Net income attributable to UHS	$	107,561		$	103,649		$	236,168		$	217,842
Less: Net income attributable to unvested restricted share grants		(126	)		(126	)		(294	)		(275	)

Net income attributable to UHS—basic and diluted	$	107,435		$	103,523		$	235,874		$	217,567

Weighted average number of common shares—basic		96,691			97,563			96,642			97,472
Net effect of dilutive stock options and grants based on the treasury stock method		1,038			1,695			1,118			1,591

Weighted average number of common shares and equivalents—diluted		97,729			99,258			97,760			99,063

Earnings per basic share attributable to UHS:	$	1.11		$	1.06		$	2.44		$	2.23

Earnings per diluted share attributable to UHS:	$	1.10		$	1.04		$	2.41		$	2.20

Pension Plan (Tables)

6 Months Ended

Jun. 30, 2012

Components of Net Periodic Pension Cost

The following table shows the components of net periodic pension cost for our defined benefit pension plan as of June 30, 2012 and 2011 (amounts in thousands):


	Three months ended June 30,						Six months ended June 30,
	2012			2011			2012			2011
Service cost	$	286		$	247		$	572		$	581
Interest cost		1,165			1,071			2,330			2,523
Expected return on assets		(2,111	)		(1,774	)		(3,651	)		(3,283	)
Recognized actuarial loss		1,055			470			2,110			1,214

Net periodic pension cost	$	395		$	14		$	1,361		$	1,035

- Definition

Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2439-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2417-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2410-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=21916443&loc=d3e4179-114921

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 4, 7, 16, 20, 21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Supplemental Condensed Consolidating Financial Information (Tables)

6 Months Ended

Jun. 30, 2012

Condensed Consolidating Statement of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,295,803		$	625,213		$	(6,553	)	$	1,914,463
Less: Provision for doubtful accounts		0			105,390			79,270			0			184,660

Net revenues		0			1,190,413			545,943			(6,553	)		1,729,803


Operating charges:
Salaries, wages and benefits		0			608,937			247,941			0			856,878
Other operating expenses		0			223,553			130,318			(6,459	)		347,412
Supplies expense		0			122,524			75,576			0			198,100
Depreciation and amortization		0			50,997			22,081			0			73,078
Lease and rental expense		0			14,394			9,703			(94	)		24,003

		0			1,020,405			485,619			(6,553	)		1,499,471


Income from operations		0			170,008			60,324			0			230,332
Interest expense		44,298			838			752			0			45,888
Interest (income) expense, affiliate		0			22,783			(22,783	)		0			0
Equity in net income of consolidated affiliates		(134,904	)		(28,548	)		0			163,452			0

Income before income taxes		90,606			174,935			82,355			(163,452	)		184,444
Provision for income taxes		(16,955	)		62,521			21,434			0			67,000

Net income		107,561			112,414			60,921			(163,452	)		117,444
Less: Income attributable to noncontrolling interests		0			0			9,883			0			9,883

Net income attributable to UHS	$	107,561		$	112,414		$	51,038		$	(163,452	)	$	107,561

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,629,267		$	1,244,287		$	(12,879	)	$	3,860,675
Less: Provision for doubtful accounts		0			194,768			138,515			0			333,283

Net revenues		0			2,434,499			1,105,772			(12,879	)		3,527,392


Operating charges:
Salaries, wages and benefits		0			1,229,795			501,077			0			1,730,872
Other operating expenses		0			459,587			254,088			(12,690	)		700,985
Supplies expense		0			250,833			152,907			0			403,740
Depreciation and amortization		0			102,256			42,714			0			144,970
Lease and rental expense		0			29,238			18,416			(189	)		47,465

		0			2,071,709			969,202			(12,879	)		3,028,032


Income from operations		0			362,790			136,570			0			499,360
Interest expense		89,452			1,625			1,521			0			92,598
Interest (income) expense, affiliate		0			45,565			(45,565	)		0			0
Equity in net income of consolidated affiliates		(291,382	)		(69,625	)		0			361,007			0

Income before income taxes		201,930			385,225			180,614			(361,007	)		406,762
Provision for income taxes		(34,238	)		136,629			44,357			0			146,748

Net income		236,168			248,596			136,257			(361,007	)		260,014
Less: Income attributable to noncontrolling interests		0			0			23,846			0			23,846

Net income attributable to UHS	$	236,168		$	248,596		$	112,411		$	(361,007	)	$	236,168

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,265,907		$	609,853		$	(6,346	)	$	1,869,414
Less: Provision for doubtful accounts		0			80,327			74,623			0			154,950

Net revenues		0			1,185,580			535,230			(6,346	)		1,714,464


Operating charges:
Salaries, wages and benefits		0			597,724			238,835			0			836,559
Other operating expenses		0			236,064			119,641			(6,251	)		349,454
Supplies expense		0			126,185			75,818			0			202,003
Depreciation and amortization		0			51,088			20,127			0			71,215
Lease and rental expense		0			15,325			7,766			(95	)		22,996

		0			1,026,386			462,187			(6,346	)		1,482,227


Income from operations		0			159,194			73,043			0			232,237
Interest expense, net		48,386			809			613			0			49,808
Interest (income) expense, affiliate		0			15,904			(15,904	)		0			0
Equity in net income of consolidated affiliates		(133,832	)		(38,049	)		0			171,881			0

Income before income taxes		85,446			180,530			88,334			(171,881	)		182,429
Provision for income taxes		(18,203	)		65,171			19,427			0			66,395

Net income		103,649			115,359			68,907			(171,881	)		116,034
Less: Income attributable to noncontrolling interests		0			0			12,385			0			12,385

Net income attributable to UHS	$	103,649		$	115,359		$	56,522		$	(171,881	)	$	103,649

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,550,935		$	1,206,560		$	(12,653	)	$	3,744,842
Less: Provision for doubtful accounts		0			170,756			133,364			0			304,120

Net revenues		0			2,380,179			1,073,196			(12,653	)		3,440,722


Operating charges:
Salaries, wages and benefits		0			1,190,926			476,391			0			1,667,317
Other operating expenses		0			467,052			234,222			(12,463	)		688,811
Supplies expense		0			253,889			151,393			0			405,282
Depreciation and amortization		0			101,721			39,088			0			140,809
Lease and rental expense		0			30,995			15,048			(190	)		45,853

		0			2,044,583			916,142			(12,653	)		2,948,072


Income from operations		0			335,596			157,054			0			492,650
Interest expense, net		103,256			1,602			1,367			0			106,225
Interest (income) expense, affiliate		0			31,808			(31,808	)		0			0
Equity in net income of consolidated affiliates		(281,440	)		(88,251	)		0			369,691			0

Income before income taxes		178,184			390,437			187,495			(369,691	)		386,425
Provision for income taxes		(39,658	)		140,132			39,930			0			140,404

Net income		217,842			250,305			147,565			(369,691	)		246,021
Less: Income attributable to noncontrolling interests		0			0			28,179			0			28,179

Net income attributable to UHS	$	217,842		$	250,305		$	119,386		$	(369,691	)	$	217,842

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	107,561		$	112,414	$	60,921	$	(163,452	)	$	117,444
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		212			0		0		0			212
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		128			0		0		0			128
Income tax expense related to items of other comprehensive income		50			0		0		0			50

Total other comprehensive income, net of tax		78			0		0		0			78


Comprehensive income		107,639			112,414		60,921		(163,452	)		117,522
Less: Comprehensive income attributable to noncontrolling interests		0			0		9,883		0			9,883

Comprehensive income attributable to UHS	$	107,639		$	112,414	$	51,038	$	(163,452	)	$	107,639

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	236,168		$	248,596	$	136,257	$	(361,007	)	$	260,014
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		1,827			0		0		0			1,827
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		1,659			0		0		0			1,659
Income tax expense related to items of other comprehensive income		632			0		0		0			632

Total other comprehensive income, net of tax		1,027			0		0		0			1,027


Comprehensive income		237,195			248,596		136,257		(361,007	)		261,041
Less: Comprehensive income attributable to noncontrolling interests		0			0		23,846		0			23,846

Comprehensive income attributable to UHS	$	237,195		$	248,596	$	112,411	$	(361,007	)	$	237,195

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	103,649		$	115,359	$	68,907	$	(171,881	)	$	116,034
Other comprehensive income (loss):
Unrealized derivative losses on cash flow hedges		(20,583	)		0		0		0			(20,583	)
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		(20,667	)		0		0		0			(20,667	)
Income tax expense related to items of other comprehensive income		(7,916	)		0		0		0			(7,916	)

Total other comprehensive income, net of tax		(12,751	)		0		0		0			(12,751	)


Comprehensive income		90,898			115,359		68,907		(171,881	)		103,283
Less: Comprehensive income attributable to noncontrolling interests		0			0		12,385		0			12,385

Comprehensive income attributable to UHS	$	90,898		$	115,359	$	56,522	$	(171,881	)	$	90,898

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	217,842		$	250,305	$	147,565	$	(369,691	)	$	246,021
Other comprehensive income (loss):
Unrealized derivative losses on cash flow hedges		(18,276	)		0		0		0			(18,276	)
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		(18,444	)		0		0		0			(18,444	)
Income tax expense related to items of other comprehensive income		(7,056	)		0		0		0			(7,056	)

Total other comprehensive income, net of tax		(11,388	)		0		0		0			(11,388	)


Comprehensive income		206,454			250,305		147,565		(369,691	)		234,633
Less: Comprehensive income attributable to noncontrolling interests		0			0		28,179		0			28,179

Comprehensive income attributable to UHS	$	206,454		$	250,305	$	119,386	$	(369,691	)	$	206,454

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF JUNE 30, 2012

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	23,148		$	9,793		$	0		$	32,941
Accounts receivable, net		3,786		705,845			310,298			0			1,019,929
Supplies		0		58,738			38,144			0			96,882
Other current assets		12,878		77,560			9,096			0			99,534
Deferred income taxes		81,565		41,230			322			(322	)		122,795
Current assets held for sale		0		84,365			0			0			84,365

Total current assets		98,229		990,886			367,653			(322	)		1,456,446

Investments in subsidiaries		5,504,955		1,251,474			0			(6,756,429	)		0
Intercompany receivable		475,833		0			129,403			(605,236	)		0
Intercompany note receivable		0		0			1,142,539			(1,142,539	)		0
Property and equipment		0		3,687,805			1,484,602			0			5,172,407
Less: accumulated depreciation		0		(1,205,261	)		(670,231	)		0			(1,875,492	)

		0		2,482,544			814,371			0			3,296,915

Other assets:
Goodwill		820		2,115,465			494,352			0			2,610,637
Deferred charges		91,728		5,986			8,381			0			106,095
Other		9,450		192,612			86,493			0			288,555

	$	6,181,015	$	7,038,967		$	3,043,192		$	(8,504,526	)	$	7,758,648


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,049		$	1,448		$	0		$	2,497
Accounts payable and accrued liabilities		27,519		620,332			204,405			0			852,256
Current liabilities held for sale		0		15,966			0			0			15,966
Federal and state taxes		12,072		201			620			0			12,893

Total current liabilities		39,591		637,548			206,473			0			883,612

Intercompany payable		0		605,236			0			(605,236	)		0
Other noncurrent liabilities		50,747		237,291			105,890			0			393,928
Long-term debt		3,405,069		1,411			52,029			0			3,458,509
Intercompany note payable		0		1,142,539			0			(1,142,539	)		0
Deferred income taxes		148,724		58,001			0			(322	)		206,403
Redeemable noncontrolling interests		0		0			226,537			0			226,537
UHS common stockholders’ equity		2,536,884		4,356,941			2,399,488			(6,756,429	)		2,536,884
Noncontrolling interest		0		0			52,775			0			52,775

Total equity		2,536,884		4,356,941			2,452,263			(6,756,429	)		2,589,659

	$	6,181,015	$	7,038,967		$	3,043,192		$	(8,504,526	)	$	7,758,648

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2011

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Other current assets		33,057		56,864			9,938			0			99,859
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			74,155			(743,267	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0
Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980


Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		743,267			0			(743,267	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592
Redeemable noncontrolling interests		0		0			218,266			0			218,266
UHS common stockholders’ equity		2,296,352		4,108,345			2,287,077			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,108,345			2,337,843			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	2,144		$	279,941		$	90,777		$	0	$	372,862

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(153,894	)		(28,457	)		0		(182,351	)
Proceeds received from sale of assets and businesses		0			49,984			3,477			0		53,461
Acquisition of property and businesses		0			(11,476	)		0					(11,476	)
Costs incurred for purchase and development of electronic health records application		0			(28,008	)		0			0		(28,008	)
Return of deposit on terminated purchase agreement		6,500			0			0			0		6,500

Net cash used in investing activities		6,500			(143,394	)		(24,980	)		0		(161,874	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(191,898	)		(2,289	)		(1,499	)		0		(195,686	)
Repurchase of common shares		(2,927	)		0			0			0		(2,927	)
Dividends paid		(9,673	)		0			0			0		(9,673	)
Issuance of common stock		2,575			0			0			0		2,575
Profit distributions to noncontrolling interests		0			0			(13,565	)		0		(13,565	)
Changes in intercompany balances with affiliates, net		193,279			(144,331	)		(48,948	)		0		0

Net cash (used in) provided by financing activities		(8,644	)		(146,620	)		(64,012	)		0		(219,276	)

Increase (decrease) in cash and cash equivalents		0			(10,073	)		1,785			0		(8,288	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0		41,229

Cash and cash equivalents, end of period	$	0		$	23,148		$	9,793		$	0	$	32,941

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	13,222		$	298,741			43,813		$	0	$	355,776


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(88,240	)		(28,000	)		0		(116,240	)
Proceeds received from sale of assets and businesses		0			2,041			0			0		2,041
Costs incurred for purchase and development of electronic health records application		0			(11,416	)		0			0		(11,416	)

Net cash used in investing activities		0			(97,615	)		(28,000	)		0		(125,615	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(188,161	)		(850	)		(11,555	)		0		(200,566	)
Additional borrowings		36,000			0			0			0		36,000
Financing costs		(23,534	)		0			0			0		(23,534	)
Repurchase of common shares		(6,163	)		0			0			0		(6,163	)
Dividends paid		(9,763	)		0			0			0		(9,763	)
Issuance of common stock		2,408			0			0			0		2,408
Profit distributions to noncontrolling interests		0			0			(23,201	)		0		(23,201	)
Changes in intercompany balances with affiliates, net		175,991			(194,187	)		18,196					0


Net cash (used in) provided by financing activities		(13,222	)		(195,037	)		(16,560	)		0		(224,819	)

Increase (decrease) in cash and cash equivalents		0			6,089			(747	)		0		5,342
Cash and cash equivalents, beginning of period		0			21,385			8,089			0		29,474

Cash and cash equivalents, end of period	$	0		$	27,474 $			7,342		$	0	$	34,816

Relationship with Universal Health Realty Income Trust and Related Party Transactions - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Dec. 31, 2010	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	$ 25,000,000
Estimated death benefit proceeds	33,000,000
Chief Executive Officer \| Trust Owned by Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	$ 8,000,000
Universal Health Realty Income Trust
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage		6.20%		6.20%
Advisory fee earned		$ 520,000	$ 480,000	$ 1,000,000	$ 951,000
Pre-tax share of income from the Trust		591,000	260,000	891,000	560,000
Carrying value of investment in Trust		9,000,000		9,000,000		$ 9,900,000
Market value of investment in Trust		32,700,000		32,700,000		$ 30,700,000
Rent expense under operating leases		$ 4,100,000	$ 4,100,000	$ 8,200,000	$ 8,300,000
Non-controlling ownership interests by subsidiaries		100.00%		100.00%
Related Party A \| Acute Care Facility
Related Party Transaction [Line Items]
Fair-market value of personal residence of president of Acute Care Division		$ 1,000,000		$ 1,000,000

Renewal Options and Terms for each of Four Hospital Facilities Leased from Trust (Detail) - Universal Health Realty Income Trust

6 Months Ended

Jun. 30, 2012

USD ($)

McAllen Medical Center

Capital Leased Assets [Line Items]

Acute Care

$ 5,485,000

2016-12

15 years

^[1]

Wellington Regional Medical Center

Capital Leased Assets [Line Items]

Acute Care

$ 3,030,000

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Capital Leased Assets [Line Items]

Acute Care

$ 2,648,000

2016-12

15 years

^[2]

The Bridgeway

Capital Leased Assets [Line Items]

Behavioral Health

$ 930,000

2014-12

10 years

^[3]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3]	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Renewal Options and Terms for each of Four Hospital Facilities Leased from Trust (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2012 Times
McAllen Medical Center
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market value lease rates	2
Renewal options term at fair market value lease rates	5 years
Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market value lease rates	2
Renewal options term at fair market value lease rates	5 years
The Bridgeway
Capital Leased Assets [Line Items]
Number of renewal options at fair market value lease rates	2
Renewal options term at fair market value lease rates	5 years
Maximum \| McAllen Medical Center
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2031
Maximum \| Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| The Bridgeway
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2024
Minimum \| Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| The Bridgeway
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2015

Other Noncurrent Liabilities and Redeemable/Noncontrolling Interests - Additional Information (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2012 USD ($) Facility	Dec. 31, 2011 USD ($)
Noncontrolling Interest [Line Items]
Redeemable noncontrolling interests	$ 227	$ 218
Noncontrolling interest	$ 53	$ 51
Acute Care Hospital Services \| Las Vegas, Nevada
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	28.00%
Number of facilities \| Facility	5
Acute Care Hospital Services \| Washington, District of Columbia
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	20.00%
Acute Care Hospital Services \| Laredo, Texas
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	11.00%
Behavioral Health Services \| Philadelphia, Pennsylvania
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	20.00%

Long-term debt and cash flow hedges - Additional Information (Detail)	1 Months Ended					3 Months Ended			6 Months Ended
	Mar. 15, 2011	Nov. 15, 2010 USD ($)	Oct. 31, 2010 USD ($)	Sep. 29, 2010 USD ($)	Jun. 30, 2006 USD ($)	Mar. 31, 2011 USD ($) Derivative	Dec. 31, 2010 USD ($) Derivative	Dec. 31, 2007 USD ($)	Jun. 30, 2012 USD ($)	May 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Jun. 30, 2008 USD ($)
Debt Instrument [Line Items]
Senior secured facility borrowing capacity		$ 3,450,000,000
Available borrowing capacity									$ 623,000,000
Line of credit facility amount outstanding									115,000,000
Letter of credit amount outstanding									62,000,000
Carrying amount of debt									3,458,509,000		$ 3,651,428,000
Fair value of debt									3,530,000,000
Derivative cap interest rate						7.00%
Interest Rate Cap from December Twenty Eleven to December Twenty Twelve
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						$ 450,000,000
Interest Rate Cap from December Twenty Twelve to December Twenty Thirteen
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						400,000,000
Interest Rate Swap
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						425,000,000	$ 600,000,000	$ 75,000,000
Premium paid on interest rate cap						$ 740,000
Number of interest rate swap \| Derivative						6	4
Interest rate maturity							2015-05	2012-10
Average fixed interest rate							2.38%	4.76%
Fair value of interest rate swap									46,000,000
Fair value of interest rate swap, current									1,000,000
Fair value of interest rate swap, non-current									$ 45,000,000
Interest Rate Swap Effective in March Twenty Eleven
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						$ 225,000,000
Number of interest rate swap \| Derivative						3
Interest rate maturity						2015-05
Average fixed interest rate						1.91%
Interest Rate Swap One Effective in December Twenty Eleven
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						$ 100,000,000
Interest rate maturity						2014-12
Fixed interest rate						2.50%
Interest Rate Swap Two Effective in December Twenty Eleven
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						$ 25,000,000
Interest rate maturity						2013-12
Fixed interest rate						1.96%
Interest Rate Swap Three Effective in December Twenty Eleven
Debt Instrument [Line Items]
Notional amount of interest rate cash flow hedges						$ 75,000,000
Interest rate maturity						2012-12
Fixed interest rate						1.32%
Federal Funds Rate
Debt Instrument [Line Items]
Interest rate	0.50%
One Month Eurodollar Rate
Debt Instrument [Line Items]
Interest rate	1.00%
ABR-based loans
Debt Instrument [Line Items]
Applicable margin rate									0.75%
Minimum \| Interest Rate Cap from December Twenty Eleven to December Twenty Twelve
Debt Instrument [Line Items]
Derivative effective date						2011-12
Minimum \| Interest Rate Cap from December Twenty Twelve to December Twenty Thirteen
Debt Instrument [Line Items]
Derivative effective date						2012-12
Maximum \| Interest Rate Cap from December Twenty Eleven to December Twenty Twelve
Debt Instrument [Line Items]
Derivative effective date						2012-12
Maximum \| Interest Rate Cap from December Twenty Twelve to December Twenty Thirteen
Debt Instrument [Line Items]
Derivative effective date						2013-12
Senior Unsecured Notes Seven Point Zero Zero Percent
Debt Instrument [Line Items]
Senior notes, issued				$ 250,000,000
Senior notes, interest rate				7.00%
Senior notes, maturity date				Oct. 01, 2018
Senior notes, frequency of periodic payment				Semiannually
Ownership interest percentage				100.00%
Senior Unsecured Notes Seven Point Zero Zero Percent \| Semi Annual Payment, First Payment
Debt Instrument [Line Items]
Senior notes, interest periodic payment				--04-01
Senior Unsecured Notes Seven Point Zero Zero Percent \| Semi Annual Payment, Second Payment
Debt Instrument [Line Items]
Senior notes, interest periodic payment				--10-01
Senior Unsecured Notes Seven Point Zero Zero Percent \| Treasury Rate
Debt Instrument [Line Items]
Interest rate				0.50%
Unsecured Notes make-whole redemption date				Oct. 01, 2014
Senior Unsecured Notes Seven Point Zero Zero Percent \| Debtor Optional Redemption Period 1
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				103.50%
Senior Unsecured Notes Seven Point Zero Zero Percent \| Debtor Optional Redemption Period 2
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				101.75%
Senior Unsecured Notes Seven Point Zero Zero Percent \| Debtor Optional Redemption Period 3
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				100.00%
Senior Unsecured Notes Seven Point Zero Zero Percent \| Minimum \| Debtor Optional Redemption Period 1
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption date				Oct. 01, 2014
Senior Unsecured Notes Seven Point Zero Zero Percent \| Minimum \| Debtor Optional Redemption Period 2
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption date				Oct. 01, 2015
Senior Unsecured Notes Seven Point Zero Zero Percent \| Minimum \| Debtor Optional Redemption Period 3
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption date				Oct. 01, 2016
Senior Notes Seven Point One Two Five Percent
Debt Instrument [Line Items]
Senior notes, issued					$ 250,000,000							$ 150,000,000
Senior notes, interest rate					7.125%							7.125%
Senior notes, maturity date					Jun. 30, 2016
Senior notes, frequency of periodic payment					Semiannually
Senior Notes Seven Point One Two Five Percent \| Semi Annual Payment, First Payment
Debt Instrument [Line Items]
Senior notes, interest periodic payment					--06-30
Senior Notes Seven Point One Two Five Percent \| Semi Annual Payment, Second Payment
Debt Instrument [Line Items]
Senior notes, interest periodic payment					--12-30
Revolving Credit Facility
Debt Instrument [Line Items]
Senior secured facility borrowing capacity		$ 800,000,000
Line of credit facility, maturity date		Nov. 15, 2015
Revolving Credit Facility \| Euro Dollar Rate
Debt Instrument [Line Items]
Applicable margin rate									1.75%
Revolving Credit Facility \| Letter of Credit
Debt Instrument [Line Items]
Senior secured facility borrowing capacity		$ 125,000,000
Revolving Credit Facility \| Minimum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	0.50%
Revolving Credit Facility \| Minimum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	1.50%
Revolving Credit Facility \| Maximum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	1.25%
Revolving Credit Facility \| Maximum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	2.25%
Term Loan A
Debt Instrument [Line Items]
Senior secured facility borrowing capacity		$ 1,050,000,000
Senior secured facility principal payments									$ 36,000,000
Line of credit facility, maturity date		Nov. 15, 2015
Term Loan A \| Euro Dollar Rate
Debt Instrument [Line Items]
Applicable margin rate									1.75%
Term Loan A \| Minimum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	0.50%
Term Loan A \| Minimum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	1.50%
Term Loan A \| Maximum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	1.25%
Term Loan A \| Maximum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	2.25%
Term Loan B
Debt Instrument [Line Items]
Senior secured facility borrowing capacity		$ 1,600,000,000
Senior secured facility principal payments						$ 125,000,000			$ 13,000,000
Line of credit facility, maturity date		Nov. 15, 2016
Fee paid on amount outstanding	1.00%
Term Loan B \| Euro Dollar Rate
Debt Instrument [Line Items]
Applicable margin rate									2.75%
Term Loan B \| Minimum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	1.75%
Term Loan B \| Minimum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	2.75%
Term Loan B \| Maximum \| One Month Eurodollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	2.00%
Term Loan B \| Maximum \| Euro Dollar Rate
Debt Instrument [Line Items]
Consolidated leverage ratio	3.00%
Term Loan B \| Before Amendment \| Minimum \| Euro Dollar Rate
Debt Instrument [Line Items]
Applicable margin rate									1.50%
Term Loan B \| After Amendment \| Minimum \| Euro Dollar Rate
Debt Instrument [Line Items]
Applicable margin rate									1.00%
Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Line of credit facility, maturity date			Oct. 25, 2013
Fee paid on amount outstanding			0.375%
Line of credit facility amount outstanding									$ 230,000,000
Commitment percentage for facility fee			102.00%
Line of credit facility additional borrowing capacity									$ 45,000,000
Senior secured facility borrowing capacity increased										$ 35,000,000
Accounts Receivable Securitization Facility \| Commercial Paper Rate
Debt Instrument [Line Items]
Interest rate			0.475%
Accounts Receivable Securitization Facility \| Before Amendment
Debt Instrument [Line Items]
Senior secured facility borrowing capacity			$ 200,000,000
Accounts Receivable Securitization Facility \| After Amendment
Debt Instrument [Line Items]
Senior secured facility borrowing capacity			$ 240,000,000							$ 275,000,000

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Jun. 30, 2012	Dec. 31, 2011	Nov. 15, 2010	Nov. 14, 2010	Jan. 01, 2008
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 288,000,000	$ 292,000,000
Self-insured for professional and general liability, current	60,000,000	60,000,000
Accounts receivable, net	1,019,929,000	969,802,000
Off-balance sheet contingent obligation	81,000,000
Illinois
Commitments and Contingencies Disclosure [Line Items]
Accounts receivable, net	72,000,000	54,000,000
Accounts receivable 60 days past due	52,000,000	$ 41,000,000
Wind Storms
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	250,000
Wind Storms \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	$ 1,000,000,000
Percentage of insurance deductible	5.00%
Wind Storms \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	3.00%
Earthquake
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	$ 250,000,000
Maximum insurance deductible	250,000
Earthquake \| United States
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	$ 100,000,000
Earthquake \| United States \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	5.00%
Earthquake \| United States \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	1.00%
Earthquake \| Puerto Rico
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	$ 25,000,000
Flood \| Location 1
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	250,000
Flood \| Location 2
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	500,000
Self Insurance Programs
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet contingent obligation	65,000,000
Other debt and public utility guarantees
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet contingent obligation	16,000,000
Subsidiaries
Commitments and Contingencies Disclosure [Line Items]
Percentage of liability for claims paid under commercially insured coverage			10.00%	10.00%
Liability for claims paid under commercially insured coverage			$ 60,000,000	$ 60,000,000
Subsidiaries \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability					$ 10,000,000
Subsidiaries \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Purchased several excess policies through commercial insurance carriers per occurrence			200,000,000	200,000,000
Psychiatric Solutions Inc
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	$ 50,000
Psychiatric Solutions Inc \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability				75,000,000
Psychiatric Solutions Inc \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability			3,000,000	$ 3,000,000
Legacy Subsidiaries
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability			$ 10,000,000

Segment Reporting (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Segment Reporting (Detail) - USD ($) $ in Thousands	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Segment Reporting Information [Line Items]
Gross inpatient revenues	$ 4,458,731	$ 4,355,903	$ 9,158,841	$ 8,902,928
Gross outpatient revenues	1,715,767	1,536,950	3,438,145	3,019,365
Total net revenues	1,729,803	1,714,464	3,527,392	3,440,722
Income/(loss) before allocation of corporate overhead and income taxes	184,444	182,429	406,762	386,425
Allocation of corporate overhead	0	0	0	0
Income/(loss) after allocation of corporate overhead and before income taxes	184,444	182,429	406,762	386,425
Total assets	7,758,648	7,565,753	7,758,648	7,565,753	$ 7,665,245
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	3,034,837	2,951,260	6,312,862	6,107,084
Gross outpatient revenues	1,540,569	1,364,531	3,089,419	2,684,482
Total net revenues	845,552	863,907	1,772,083	1,755,295
Income/(loss) before allocation of corporate overhead and income taxes	61,602	91,145	191,450	218,129
Allocation of corporate overhead	(37,979)	(30,518)	(78,722)	(63,324)
Income/(loss) after allocation of corporate overhead and before income taxes	23,623	60,627	112,728	154,805
Total assets	2,957,192	2,779,803	2,957,192	2,779,803
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	1,423,894	1,404,643	2,845,979	2,795,844
Gross outpatient revenues	162,475	157,748	323,733	307,343
Total net revenues	875,031	844,734	1,739,904	1,673,678
Income/(loss) before allocation of corporate overhead and income taxes	224,963	189,590	427,459	375,378
Allocation of corporate overhead	(21,071)	(15,691)	(42,132)	(31,416)
Income/(loss) after allocation of corporate overhead and before income taxes	203,892	173,899	385,327	343,962
Total assets	4,431,758	4,381,320	4,431,758	4,381,320
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues	12,723	14,671	24,993	27,540
Total net revenues	9,220	5,823	15,405	11,749
Income/(loss) before allocation of corporate overhead and income taxes	(102,121)	(98,306)	(212,147)	(207,082)
Allocation of corporate overhead	59,050	46,209	120,854	94,740
Income/(loss) after allocation of corporate overhead and before income taxes	(43,071)	(52,097)	(91,293)	(112,342)
Total assets	$ 369,698	$ 404,630	$ 369,698	$ 404,630

Computation of Basic and Diluted Earnings per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Earnings Per Share Basic And Diluted [Line Items]
Net income attributable to UHS	$ 107,561	$ 103,649	$ 236,168	$ 217,842
Less: Net income attributable to unvested restricted share grants	(126)	(126)	(294)	(275)
Net income attributable to UHS-basic and diluted	$ 107,435	$ 103,523	$ 235,874	$ 217,567
Weighted average number of common shares-basic	96,691	97,563	96,642	97,472
Net effect of dilutive stock options and grants based on the treasury stock method	1,038	1,695	1,118	1,591
Weighted average number of common shares and equivalents-diluted	97,729	99,258	97,760	99,063
Earnings per basic share attributable to UHS:	$ 1.11	$ 1.06	$ 2.44	$ 2.23
Earnings per diluted share attributable to UHS:	$ 1.10	$ 1.04	$ 2.41	$ 2.20

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=16381557&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 36, 37, 38
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 10, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A7
-Appendix A

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 87-21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28, 29, 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

+ Details

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References + Details

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 171
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average stock options excluded from antidilutive securities	2,600,000		2,600,000
Unrecognized compensation cost related to unvested options and restricted stock	$ 45,300,000		$ 45,300,000
Unrecognized compensation cost, remaining weighted average vesting period in years			2 years 10 months 24 days
Stock options granted during period (net of cancellations)			2,870,200
Weighted-average grant date fair value, per share			$ 10.72
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	4,700,000	$ 4,200,000	$ 9,600,000	$ 7,700,000
Compensation cost recognized, after-tax	2,900,000	2,600,000	6,000,000	4,700,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	593,000	455,000	1,200,000	906,000
Compensation cost recognized, after-tax	$ 369,000	$ 281,000	$ 727,000	$ 559,000
Restricted stock shares granted			54,127
Weighted-average grant date fair value, per share			$ 36.95

Dispositions and acquisitions - Additional Information (Detail) $ in Millions	6 Months Ended
	Jun. 30, 2012 USD ($) State Facility	Jun. 30, 2011 USD ($)
Significant Acquisitions and Disposals [Line Items]
Acquisition of a physician practice and various real properties	$ 11.0
Return of deposit on terminated purchase agreement	6.5
Aggregate cash proceeds from divestiture of businesses	53.0
Ascend Health Corporation
Significant Acquisitions and Disposals [Line Items]
Business acquisition, cash paid	500.0
Business acquisition, assumed liabilities	17.0
Business acquisition, purchase price	$ 517.0
Number of psychiatric inpatient facilities \| Facility	9
Number of states facilities located \| State	5
Acute Care Hospital Services
Significant Acquisitions and Disposals [Line Items]
Net cash proceeds from the sale of a closed acute care hospital		$ 2.0
Hospital San Juan Capestrano
Significant Acquisitions and Disposals [Line Items]
Number of acute care hospital beds included in sale	108
Auburn Regional Medical Center
Significant Acquisitions and Disposals [Line Items]
Aggregate cash proceeds from divestiture of businesses	$ 98.0
Number of acute care hospital beds included in sale	213

Dividends - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Dividends [Line Items]
Declared and paid dividends	$ 4.8	$ 4.9	$ 9.7	$ 9.8
Declared and paid dividends, per share	$ 0.05	$ 0.05

Components of Net Periodic Pension Cost (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 286	$ 247	$ 572	$ 581
Interest cost	1,165	1,071	2,330	2,523
Expected return on assets	(2,111)	(1,774)	(3,651)	(3,283)
Recognized actuarial loss	1,055	470	2,110	1,214
Net periodic pension cost	$ 395	$ 14	$ 1,361	$ 1,035

- Definition

An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 30
-Glossary Expected Return on Plan Assets
-URI http://asc.fasb.org/extlink&oid=6512136

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Glossary Expected Return on Plan Assets
-URI http://asc.fasb.org/extlink&oid=6512171

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(3)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.

+ References + Details

- Definition

The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Service Cost (Component of Net Periodic Pension Cost)
-URI http://asc.fasb.org/extlink&oid=6525008

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a, h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Pension Plan - Additional Information (Detail) $ in Millions	6 Months Ended
	Jun. 30, 2012 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Total contributions to pension plan	$ 7.1

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2012	Dec. 31, 2011
Income Tax [Line Items]
Unrecognized tax benefits		$ 7
Impact of unrecognized tax benefits if recognized		$ 5
Accrued interest and penalties	$ 1
Jurisdictions statutes of limitations expiration period	12 months
Minimum
Income Tax [Line Items]
Foreign, U.S. state and local jurisdictions statutes of limitations	3 years
Maximum
Income Tax [Line Items]
Foreign, U.S. state and local jurisdictions statutes of limitations	4 years

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail)	Jun. 30, 2012
Guarantors
Condensed Financial Statements, Captions [Line Items]
Percentage of ownership interests	100.00%

Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	$ 1,914,463	$ 1,869,414	$ 3,860,675	$ 3,744,842
Less: Provision for doubtful accounts	184,660	154,950	333,283	304,120
Net revenues	1,729,803	1,714,464	3,527,392	3,440,722
Operating charges:
Salaries, wages and benefits	856,878	836,559	1,730,872	1,667,317
Other operating expenses	347,412	349,454	700,985	688,811
Supplies expense	198,100	202,003	403,740	405,282
Depreciation and amortization	73,078	71,215	144,970	140,809
Lease and rental expense	24,003	22,996	47,465	45,853
Operating Expenses	1,499,471	1,482,227	3,028,032	2,948,072
Income from operations	230,332	232,237	499,360	492,650
Interest expense, net	45,888	49,808	92,598	106,225
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	0	0	0	0
Income before income taxes	184,444	182,429	406,762	386,425
Provision for income taxes	67,000	66,395	146,748	140,404
Net income	117,444	116,034	260,014	246,021
Less: Income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Net income attributable to UHS	107,561	103,649	236,168	217,842
Parent
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	0	0	0	0
Less: Provision for doubtful accounts	0	0	0	0
Net revenues	0	0	0	0
Operating charges:
Salaries, wages and benefits	0	0	0	0
Other operating expenses	0	0	0	0
Supplies expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Lease and rental expense	0	0	0	0
Operating Expenses	0	0	0	0
Income from operations	0	0	0	0
Interest expense, net	44,298	48,386	89,452	103,256
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	(134,904)	(133,832)	(291,382)	(281,440)
Income before income taxes	90,606	85,446	201,930	178,184
Provision for income taxes	(16,955)	(18,203)	(34,238)	(39,658)
Net income	107,561	103,649	236,168	217,842
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	107,561	103,649	236,168	217,842
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	1,295,803	1,265,907	2,629,267	2,550,935
Less: Provision for doubtful accounts	105,390	80,327	194,768	170,756
Net revenues	1,190,413	1,185,580	2,434,499	2,380,179
Operating charges:
Salaries, wages and benefits	608,937	597,724	1,229,795	1,190,926
Other operating expenses	223,553	236,064	459,587	467,052
Supplies expense	122,524	126,185	250,833	253,889
Depreciation and amortization	50,997	51,088	102,256	101,721
Lease and rental expense	14,394	15,325	29,238	30,995
Operating Expenses	1,020,405	1,026,386	2,071,709	2,044,583
Income from operations	170,008	159,194	362,790	335,596
Interest expense, net	838	809	1,625	1,602
Interest (income) expense, affiliate	22,783	15,904	45,565	31,808
Equity in net income of consolidated affiliates	(28,548)	(38,049)	(69,625)	(88,251)
Income before income taxes	174,935	180,530	385,225	390,437
Provision for income taxes	62,521	65,171	136,629	140,132
Net income	112,414	115,359	248,596	250,305
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	112,414	115,359	248,596	250,305
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	625,213	609,853	1,244,287	1,206,560
Less: Provision for doubtful accounts	79,270	74,623	138,515	133,364
Net revenues	545,943	535,230	1,105,772	1,073,196
Operating charges:
Salaries, wages and benefits	247,941	238,835	501,077	476,391
Other operating expenses	130,318	119,641	254,088	234,222
Supplies expense	75,576	75,818	152,907	151,393
Depreciation and amortization	22,081	20,127	42,714	39,088
Lease and rental expense	9,703	7,766	18,416	15,048
Operating Expenses	485,619	462,187	969,202	916,142
Income from operations	60,324	73,043	136,570	157,054
Interest expense, net	752	613	1,521	1,367
Interest (income) expense, affiliate	(22,783)	(15,904)	(45,565)	(31,808)
Equity in net income of consolidated affiliates	0	0	0	0
Income before income taxes	82,355	88,334	180,614	187,495
Provision for income taxes	21,434	19,427	44,357	39,930
Net income	60,921	68,907	136,257	147,565
Less: Income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Net income attributable to UHS	51,038	56,522	112,411	119,386
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	(6,553)	(6,346)	(12,879)	(12,653)
Less: Provision for doubtful accounts	0	0	0	0
Net revenues	(6,553)	(6,346)	(12,879)	(12,653)
Operating charges:
Salaries, wages and benefits	0	0	0	0
Other operating expenses	(6,459)	(6,251)	(12,690)	(12,463)
Supplies expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Lease and rental expense	(94)	(95)	(189)	(190)
Operating Expenses	(6,553)	(6,346)	(12,879)	(12,653)
Income from operations	0	0	0	0
Interest expense, net	0	0	0	0
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	163,452	171,881	361,007	369,691
Income before income taxes	(163,452)	(171,881)	(361,007)	(369,691)
Provision for income taxes	0	0	0	0
Net income	(163,452)	(171,881)	(361,007)	(369,691)
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	$ (163,452)	$ (171,881)	$ (361,007)	$ (369,691)

Condensed Consolidating Statements of Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Condensed Financial Statements, Captions [Line Items]
Net income	$ 117,444	$ 116,034	$ 260,014	$ 246,021
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	212	(20,583)	1,827	(18,276)
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income before tax	128	(20,667)	1,659	(18,444)
Income tax expense related to items of other comprehensive income	50	(7,916)	632	(7,056)
Total other comprehensive income, net of tax	78	(12,751)	1,027	(11,388)
Comprehensive income	117,522	103,283	261,041	234,633
Less: Comprehensive income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Comprehensive income attributable to UHS	107,639	90,898	237,195	206,454
Parent
Condensed Financial Statements, Captions [Line Items]
Net income	107,561	103,649	236,168	217,842
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	212	(20,583)	1,827	(18,276)
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income before tax	128	(20,667)	1,659	(18,444)
Income tax expense related to items of other comprehensive income	50	(7,916)	632	(7,056)
Total other comprehensive income, net of tax	78	(12,751)	1,027	(11,388)
Comprehensive income	107,639	90,898	237,195	206,454
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	107,639	90,898	237,195	206,454
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net income	112,414	115,359	248,596	250,305
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income before tax	0	0	0	0
Income tax expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	112,414	115,359	248,596	250,305
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	112,414	115,359	248,596	250,305
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net income	60,921	68,907	136,257	147,565
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income before tax	0	0	0	0
Income tax expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	60,921	68,907	136,257	147,565
Less: Comprehensive income attributable to noncontrolling interests	9,883	12,385	23,846	28,179
Comprehensive income attributable to UHS	51,038	56,522	112,411	119,386
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net income	(163,452)	(171,881)	(361,007)	(369,691)
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income before tax	0	0	0	0
Income tax expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	(163,452)	(171,881)	(361,007)	(369,691)
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	$ (163,452)	$ (171,881)	$ (361,007)	$ (369,691)

Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 32,941	$ 41,229	$ 34,816	$ 29,474
Accounts receivable, net	1,019,929	969,802
Supplies	96,882	96,775
Other current assets	99,534	99,859
Deferred income taxes	122,795	108,324
Current assets held for sale	84,365	48,916
Total current assets	1,456,446	1,364,905
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	5,172,407	5,106,160
Less: accumulated depreciation	(1,875,492)	(1,818,180)
Property, Plant and Equipment, Net	3,296,915	3,287,980
Other assets:
Goodwill	2,610,637	2,627,602
Deferred charges	106,095	111,780
Other	288,555	272,978
Total assets	7,758,648	7,665,245	7,565,753
Current liabilities:
Current maturities of long-term debt	2,497	2,479
Accounts payable and accrued liabilities	852,256	832,125
Current liabilities held for sale	15,966	2,329
Federal and state taxes	12,893	0
Total current liabilities	883,612	836,933
Intercompany payable	0	0
Other noncurrent liabilities	393,928	401,908
Long-term debt	3,458,509	3,651,428
Intercompany note payable	0	0
Deferred income taxes	206,403	209,592
Redeemable noncontrolling interests	226,537	218,266
UHS common stockholders' equity	2,536,884	2,296,352
Noncontrolling interest	52,775	50,766
Total equity	2,589,659	2,347,118
Liabilities and Equity, Total	7,758,648	7,665,245
Parent
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	3,786	8,891
Supplies	0	0
Other current assets	12,878	33,057
Deferred income taxes	81,565	67,189
Current assets held for sale	0	0
Total current assets	98,229	109,137
Investments in subsidiaries	5,504,955	5,213,573
Intercompany receivable	475,833	669,112
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	820	820
Deferred charges	91,728	103,434
Other	9,450	10,412
Total assets	6,181,015	6,106,488
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	27,519	14,201
Current liabilities held for sale	0	0
Federal and state taxes	12,072	0
Total current liabilities	39,591	14,201
Intercompany payable	0	0
Other noncurrent liabilities	50,747	49,840
Long-term debt	3,405,069	3,594,182
Intercompany note payable	0	0
Deferred income taxes	148,724	151,913
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	2,536,884	2,296,352
Noncontrolling interest	0	0
Total equity	2,536,884	2,296,352
Liabilities and Equity, Total	6,181,015	6,106,488
Guarantors
Current assets:
Cash and cash equivalents	23,148	33,221	27,474	21,385
Accounts receivable, net	705,845	663,593
Supplies	58,738	59,467
Other current assets	77,560	56,864
Deferred income taxes	41,230	41,755
Current assets held for sale	84,365	48,916
Total current assets	990,886	903,816
Investments in subsidiaries	1,251,474	1,181,849
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	3,687,805	3,650,025
Less: accumulated depreciation	(1,205,261)	(1,184,283)
Property, Plant and Equipment, Net	2,482,544	2,465,742
Other assets:
Goodwill	2,115,465	2,132,103
Deferred charges	5,986	5,972
Other	192,612	241,107
Total assets	7,038,967	6,930,589
Current liabilities:
Current maturities of long-term debt	1,049	1,133
Accounts payable and accrued liabilities	620,332	616,026
Current liabilities held for sale	15,966	2,329
Federal and state taxes	201	0
Total current liabilities	637,548	619,488
Intercompany payable	605,236	743,267
Other noncurrent liabilities	237,291	249,033
Long-term debt	1,411	3,616
Intercompany note payable	1,142,539	1,148,839
Deferred income taxes	58,001	58,001
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	4,356,941	4,108,345
Noncontrolling interest	0	0
Total equity	4,356,941	4,108,345
Liabilities and Equity, Total	7,038,967	6,930,589
Non Guarantors
Current assets:
Cash and cash equivalents	9,793	8,008	7,342	8,089
Accounts receivable, net	310,298	297,318
Supplies	38,144	37,308
Other current assets	9,096	9,938
Deferred income taxes	322	322
Current assets held for sale	0	0
Total current assets	367,653	352,894
Investments in subsidiaries	0	0
Intercompany receivable	129,403	74,155
Intercompany note receivable	1,142,539	1,148,839
Property and equipment	1,484,602	1,456,135
Less: accumulated depreciation	(670,231)	(633,897)
Property, Plant and Equipment, Net	814,371	822,238
Other assets:
Goodwill	494,352	494,679
Deferred charges	8,381	2,374
Other	86,493	21,459
Total assets	3,043,192	2,916,638
Current liabilities:
Current maturities of long-term debt	1,448	1,346
Accounts payable and accrued liabilities	204,405	201,898
Current liabilities held for sale	0	0
Federal and state taxes	620	620
Total current liabilities	206,473	203,864
Intercompany payable	0	0
Other noncurrent liabilities	105,890	103,035
Long-term debt	52,029	53,630
Intercompany note payable	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	226,537	218,266
UHS common stockholders' equity	2,399,488	2,287,077
Noncontrolling interest	52,775	50,766
Total equity	2,452,263	2,337,843
Liabilities and Equity, Total	3,043,192	2,916,638
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable, net	0	0
Supplies	0	0
Other current assets	0	0
Deferred income taxes	(322)	(942)
Current assets held for sale	0	0
Total current assets	(322)	(942)
Investments in subsidiaries	(6,756,429)	(6,395,422)
Intercompany receivable	(605,236)	(743,267)
Intercompany note receivable	(1,142,539)	(1,148,839)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(8,504,526)	(8,288,470)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Current liabilities held for sale	0	0
Federal and state taxes	0	(620)
Total current liabilities	0	(620)
Intercompany payable	(605,236)	(743,267)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,142,539)	(1,148,839)
Deferred income taxes	(322)	(322)
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	(6,756,429)	(6,395,422)
Noncontrolling interest	0	0
Total equity	(6,756,429)	(6,395,422)
Liabilities and Equity, Total	$ (8,504,526)	$ (8,288,470)

Condensed Consolidating Statements of Cash Flows (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	$ 372,862	$ 355,776
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(182,351)	(116,240)
Proceeds received from sale of assets and businesses	53,461	2,041
Acquisition of property and businesses	(11,476)	0
Costs incurred for purchase and development of electronic health records application	(28,008)	(11,416)
Return of deposit on terminated purchase agreement	6,500	0
Net cash used in investing activities	(161,874)	(125,615)
Cash Flows from Financing Activities:
Reduction of long-term debt	(195,686)	(200,566)
Additional borrowings	0	36,000
Financing costs	0	(23,534)
Repurchase of common shares	(2,927)	(6,163)
Dividends paid	(9,673)	(9,763)
Issuance of common stock	2,575	2,408
Profit distributions to noncontrolling interests	(13,565)	(23,201)
Changes in intercompany balances with affiliates, net	0	0
Net cash (used in) provided by financing activities	(219,276)	(224,819)
Increase (decrease) in cash and cash equivalents	(8,288)	5,342
Cash and cash equivalents, beginning of period	41,229	29,474
Cash and cash equivalents, end of period	32,941	34,816
Parent
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	2,144	13,222
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Acquisition of property and businesses	0
Costs incurred for purchase and development of electronic health records application	0	0
Return of deposit on terminated purchase agreement	6,500
Net cash used in investing activities	6,500	0
Cash Flows from Financing Activities:
Reduction of long-term debt	(191,898)	(188,161)
Additional borrowings		36,000
Financing costs		(23,534)
Repurchase of common shares	(2,927)	(6,163)
Dividends paid	(9,673)	(9,763)
Issuance of common stock	2,575	2,408
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	193,279	175,991
Net cash (used in) provided by financing activities	(8,644)	(13,222)
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	279,941	298,741
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(153,894)	(88,240)
Proceeds received from sale of assets and businesses	49,984	2,041
Acquisition of property and businesses	(11,476)
Costs incurred for purchase and development of electronic health records application	(28,008)	(11,416)
Return of deposit on terminated purchase agreement	0
Net cash used in investing activities	(143,394)	(97,615)
Cash Flows from Financing Activities:
Reduction of long-term debt	(2,289)	(850)
Additional borrowings		0
Financing costs		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	(144,331)	(194,187)
Net cash (used in) provided by financing activities	(146,620)	(195,037)
Increase (decrease) in cash and cash equivalents	(10,073)	6,089
Cash and cash equivalents, beginning of period	33,221	21,385
Cash and cash equivalents, end of period	23,148	27,474
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	90,777	43,813
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(28,457)	(28,000)
Proceeds received from sale of assets and businesses	3,477	0
Acquisition of property and businesses	0
Costs incurred for purchase and development of electronic health records application	0	0
Return of deposit on terminated purchase agreement	0
Net cash used in investing activities	(24,980)	(28,000)
Cash Flows from Financing Activities:
Reduction of long-term debt	(1,499)	(11,555)
Additional borrowings		0
Financing costs		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Profit distributions to noncontrolling interests	(13,565)	(23,201)
Changes in intercompany balances with affiliates, net	(48,948)	18,196
Net cash (used in) provided by financing activities	(64,012)	(16,560)
Increase (decrease) in cash and cash equivalents	1,785	(747)
Cash and cash equivalents, beginning of period	8,008	8,089
Cash and cash equivalents, end of period	9,793	7,342
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Costs incurred for purchase and development of electronic health records application	0	0
Return of deposit on terminated purchase agreement	0
Net cash used in investing activities	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	0	0
Additional borrowings		0
Financing costs		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	0
Net cash (used in) provided by financing activities	0	0
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0